METHOD USING GENETIC PROFILING OF BIOAVAILABILITY OR BIOEQUIVALENCE OF XENOBIOTICS

摘要

This invention provides: a method that selects test objects (human beings or animals) based on genetic profiling such as metabolic enzymes or transporters affecting pharmacokinetics (PK) or pharmacodynamics (PD), and tests the test objects' bioavailability or bioequivalence of xenobiotics; and a method that is used in the analysis of the bioavailability or bioequivalence test by using the genetic information of the test objects after performing the test.